drugset / Trial / NCT03723083

Expanded Access for CC-2001

NCT03723083 ↗

Expanded access No longer available Celgene Corporation

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-2001.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background CC-2001 Unknown — Oral

Indications